ino-a002
Vaccineexperimental
Clinical trial activity
4 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 7, 2019 (NCT03831503)
Timeline
Indications
Mechanism of action
- Zika virusImmunity, active
immunity, active - zika virus
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07073677 | Phase 2 | Jul 31, 2025 | Inno.N, Korea University |
| NCT05729074 | Phase 1 | Feb 13, 2023 | Chonbuk National University, Inno.N |
| NCT05019755 | Phase 1 | Aug 13, 2021 | Inno.N, Seoul National University |
| NCT03831503 | Phase 1 | Feb 7, 2019 | Inovio Pharmaceuticals, University of Pennsylvania |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Inno.N | For profit | 3 | 3 | 2 | 2021 |
| Chonbuk National University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Inovio Pharmaceuticals | For profit | 1 | 0 | 1 | 2019 |
| Korea University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Seoul National University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Pennsylvania | Academic/Hospital | 1 | 1 | 1 | 2019 |
6 organizations
Page 1 / 1